SCHEMBL13623265

SCHEMBL13623265

COc1ccc2cc(N3c4ccccc4Oc4cc(-c5ccc(-c6ccc7c(c6)Oc6ccccc6N7c6ccc7cc(OC)ccc7c6)cc5)ccc43)ccc2c1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 5/20 0.42
CYP11B1 P15538 4/20 0.42
CYP1A2 P05177 2/20 0.41
CYP2A6 P11509 1/20 0.41
HSD17B1 P14061 1/20 0.40
HSD17B2 P37059 1/20 0.40
CYP17A1 P05093 3/20 0.37
CYP19A1 P11511 1/20 0.37
BACE1 P56817 1/20 0.37
P2RX4 Q99571 1/20 0.37
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
HTR1A P08908 1/20 0.36
HTR1D P28221 1/20 0.36
HTR1B P28222 1/20 0.36
TRPA1 O75762 1/20 0.36
MAPT P10636 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13623268 0.93 CYP11B1 (0.38) CYP11B2CYP11B1CYP1A2CYP2A6HSD17B1
SCHEMBL13623272 0.91 CYP2A6 (0.49) CYP11B2CYP11B1CYP1A2CYP2A6P2RX4
SCHEMBL13623266 0.91 EDNRA (0.39) CYP11B2CYP11B1CYP1A2CYP2A6HSD17B1
SCHEMBL13623264 0.91 CYP11B1 (0.42) CYP11B2CYP11B1CYP1A2CYP2A6HSD17B1
SCHEMBL14667911 0.88 CYP1A2 (0.41) CYP11B2CYP11B1CYP1A2CYP2A6P2RX4
SCHEMBL13623271 0.86 CYP1A2 (0.40) CYP11B2CYP11B1CYP1A2CYP2A6P2RX4
SCHEMBL13623278 0.86 CYP1A2 (0.38) CYP11B2CYP11B1CYP1A2CYP2A6CYP3A4
SCHEMBL23220372 0.86 KDR (0.43) BACE1P2RX4MAPT
SCHEMBL13030181 0.85 HSD17B1 (0.36) CYP11B2CYP11B1CYP1A2CYP2A6HSD17B1
SCHEMBL13623270 0.81 LPL (0.40) CYP11B2CYP11B1CYP1A2CYP2A6P2RX4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7619246-B2 Organic light emitting compound and organic light emitting device comprising the same SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2009-11-17 US disclosed
US-7619246-B2 Organic light emitting compound and organic light emitting device comprising the same SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2009-11-17 US disclosed
US-20070176541-A1 Organic light emitting compound and organic light emitting device comprising the same SAMSUNG DISPLAY CO., LTD. (KR) 2007-08-02 US disclosed
US-20070176541-A1 Organic light emitting compound and organic light emitting device comprising the same SAMSUNG DISPLAY CO., LTD. (KR) 2007-08-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070176541-A1 Organic light emitting compound and organic light emitting device comprising the same C1S, OR10J3, C1R CYP11B2 1100/4885CYP11B1 910/4885CYP1A2 180/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.